{
    "clinical_study": {
        "@rank": "82186", 
        "arm_group": {
            "arm_group_label": "S. boulardii 200mg (Floratil\u00ae)", 
            "arm_group_type": "Experimental", 
            "description": "The patients received S. boulardii every 8h during 30 days as an oral capsule formulation which contained 200 mg lyophilized S. boulardii-17 (Floratil\u00ae).\nThe patients enrolled in the study were evaluated immediately before the beginning of treatment, after a thirty-day period of treatment with probiotic and at the end of the second study month (after a thirty-day period without treatment with probiotic)."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the effect of Saccharomyces boulardii  in patients\n      in the waiting list for liver transplant."
        }, 
        "brief_title": "Effect of Saccharomyces Boulardii in Patients in the Waiting List for Liver Transplant", 
        "completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "condition": "Liver Cirrhosis", 
        "condition_browse": {
            "mesh_term": [
                "Liver Cirrhosis", 
                "Fibrosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "Increased intestinal permeability are related to the major complications of liver cirrhosis.\n      The administration of probiotics has been suggested to improve the barrier function of the\n      mucosa and consequently avoid the complications of the disease. The objective of this study\n      was to evaluate the effect of Saccharomyces boulardii in patients in the waiting list for\n      liver transplant.\n\n      Eighteen patients were treated with Saccharomyces boulardii. Intestinal permeability\n      (lactulose/mannitol ratio) and laboratory parameters were evaluated immediately before the\n      beginning of treatment, after a thirty-day period of treatment with probiotic and at the end\n      of the second study month (after a thirty-day period without treatment with probiotic).\n      Twenty healthy volunteers were also submitted for the intestinal permeability test."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients in the waiting list for liver transplant with viral, alcoholic or\n             cryptogenic cirrhosis\n\n        Exclusion Criteria:\n\n          -  patients younger than 18 years or older than 65 years.\n\n          -  patients with renal failure, congestive heart failure, nephrotic syndrome, diabetes\n             and thyroid diseases that interfered with absorption, flux of water and solutes and\n             intestinal motility, in order to avoid interference with the intestinal permeability\n             tests"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "18", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01762748", 
            "org_study_id": "ETIC 0609.0.203.000-09"
        }, 
        "intervention": {
            "arm_group_label": "S. boulardii 200mg (Floratil\u00ae)", 
            "description": "Oral capsule with 200 mg lyophilized S. boulardii-17 (about 4x108 cells), 6 mg sucrose and 2.4 mg magnesium stearate (Floratil\u00ae).", 
            "intervention_name": "Saccharomyces boulardii", 
            "intervention_type": "Drug", 
            "other_name": "Floratil"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Probiotic", 
            "liver", 
            "transplant", 
            "permeability"
        ], 
        "lastchanged_date": "January 8, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Belo Horizonte", 
                    "country": "Brazil", 
                    "state": "Minas Gerais"
                }, 
                "name": "Alfa Institute of Gastroenterology - Transplant Outpatient Clinic at Federal University of Minas Gerais"
            }
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "1", 
        "official_title": "Effect of Saccharomyces Boulardii in Patients in the Waiting List for Liver Transplant", 
        "overall_official": [
            {
                "affiliation": "Federal University of Minas Gerais", 
                "last_name": "Maria Isabel Correia, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Federal University of Minas Gerais", 
                "last_name": "Juliana Liboredo, PhD degree", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Brazil: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Intestinal permeability test was conducted at the lactulose and mannitol excretion", 
            "measure": "Intestinal permeability", 
            "safety_issue": "No", 
            "time_frame": "Change from intestinal permeability at two months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01762748"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Federal University of Minas Gerais", 
            "investigator_full_name": "Juliana Costa Liboredo", 
            "investigator_title": "Fellow PhD degree", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Effect of Saccharomyces boulardii on laboratory parameters", 
                "safety_issue": "No", 
                "time_frame": "Change from laboratory parameters in two months"
            }, 
            {
                "measure": "Number of participants with adverse effect", 
                "safety_issue": "Yes", 
                "time_frame": "Adverse effect in two months"
            }
        ], 
        "source": "Federal University of Minas Gerais", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Federal University of Minas Gerais", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2011", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}